Bath & Body Works (NYSE:BBWI) Trading Up 4.8% – Here’s What Happened

Bath & Body Works, Inc. (NYSE:BBWIGet Free Report)’s stock price rose 4.8% during mid-day trading on Tuesday . The stock traded as high as $20.60 and last traded at $20.58. Approximately 511,816 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 5,734,738 shares. The stock had previously closed at $19.63.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on BBWI shares. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research note on Tuesday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Tuesday, March 3rd. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. Weiss Ratings lowered Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, June 2nd. Finally, Barclays decreased their price target on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 28th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $22.00.

Check Out Our Latest Research Report on Bath & Body Works

Bath & Body Works Price Performance

The company has a market cap of $4.19 billion, a price-to-earnings ratio of 5.84, a PEG ratio of 2.04 and a beta of 1.42. The business’s 50-day simple moving average is $18.85 and its 200-day simple moving average is $20.21.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period in the prior year, the business earned $0.49 earnings per share. The company’s quarterly revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 2.62 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 19th. Shareholders of record on Friday, June 5th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio is 22.47%.

Institutional Trading of Bath & Body Works

Institutional investors and hedge funds have recently made changes to their positions in the stock. Global Retirement Partners LLC purchased a new stake in Bath & Body Works during the 4th quarter worth about $31,000. Activest Wealth Management acquired a new stake in shares of Bath & Body Works during the 4th quarter worth about $32,000. Geneos Wealth Management Inc. boosted its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after buying an additional 567 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in shares of Bath & Body Works during the third quarter worth about $39,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

See Also

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.